From Words to Outcomes: Transforming Care for Alcohol-Associated Liver Disease, Part 2

Nov 06 2026
Convention Center: Bluebird Ballroom 1B
2:00 PM - 3:30 PM
Captured/recorded session Recorded
CE Credits CE Credits

Description

Jointly planned by the Alcohol-Associated Liver Disease and Public Health/Health Delivery Special Interest Groups, this 2-part symposium examines transformation of care for alcohol-associated liver disease (ALD) through the lens of health delivery and engagement to improve outcomes. Key concepts explored in part 2 of the symposium include: Leveraging biomarkers in alcohol use disorder and ALD screening and treatment Impact of cardiometabolic risk factors in ALD Strategies to implement alcohol use care in clinical practice Leveraging health impacts of alcohol beyond the liver to increase care engagement Alcohol policy as liver disease prevention and treatment

Presentations

2:15 PM - 2:30 PM
Convention Center - Bluebird Ballroom 1B
Recorded session

Leveraging Biomarkers in Alcohol Use Disorder and Alcohol-Associated Liver Disease Screening and Treatment

Juan Pablo Arab, MD, FRCPC | Presenter
2:30 PM - 2:45 PM
Convention Center - Bluebird Ballroom 1B
Recorded session

Impact of Cardiometabolic Risk Factors in Alcohol-Associated Liver Disease

Brian P Lee, MD MAS | Presenter
2:45 PM - 3:00 PM
Convention Center - Bluebird Ballroom 1B
Recorded session

Strategies to Implement Alcohol Use Care at Your Center

Shari Rogal, MD, MPH, FAASLD | Presenter
3:00 PM - 3:15 PM
Convention Center - Bluebird Ballroom 1B
Recorded session

Leveraging Health Impacts of Alcohol Beyond the Liver to Increase Care Engagement

Gene Y. Im, MD, , FAASLD | Presenter

Objectives

  • Explain the population-level impacts of minimum-unit pricing (MUP) on alcohol-associated outcomes.
  • Examine how biomarkers of alcohol and liver fibrosis can be leveraged to improve care.
  • Summarize how alcohol affects health beyond the liver and how cardiometabolic risk factors impact alcohol-associated liver disease.